Controlled-release tablets from carrageenans: effect of formulation, storage and dissolution factors

被引:64
作者
Gupta, VK
Hariharan, M
Wheatley, TA
Price, JC
机构
[1] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA
[2] Pharmacia Corp, Pharmaceut & Analyt Sci, Skokie, IL USA
[3] FMC Corp, Div Pharmaceut, Princeton, NJ USA
关键词
controlled-release; sustained-release; zero-order; iota-carrageenan; lambda-carrageenan; tablets;
D O I
10.1016/S0939-6411(01)00135-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to investigate the potential of two carrageenans, tau -carrageenan and lambda -carrageenan for the preparation of controlled-release tablets. Tablets were compressed on a Carver press and the effect of formulation factors, moisture, and storage on the release of theophylline was studied. The effect of sodium chloride in the tablet formulation and a change in the ionic strength of the dissolution media was studied on the release of three model drugs. The release rate increased both with an increase in tablet diameter and increase in drug to carrageenan ratio in the tablets. The two lubricants studied had a negligible effect on the rate of drug release at their commonly used concentrations. Moisture content of carrageenans, storage of tablets at 37 degreesC/75% RH for 3 months, and incorporation of 10% sodium chloride in the tablets did not have any significant effect on the release rate. The change in ionic strength of simulated gastric fluid altered the release rate whereas the ionic strength of simulated intestinal fluid did not have a significant effect on the release rate. Carrageenan tablets were relatively insensitive to small changes in formulation parameters and dissolution conditions. (C) 2001 Elsevier Science B.V, All rights reserved.
引用
收藏
页码:241 / 248
页数:8
相关论文
共 20 条
  • [1] ABOUNASSIF MA, 1994, ANAL PROFILES DRUG S, V23, P422
  • [2] RELEASE MECHANISMS IN GELFORMING SUSTAINED-RELEASE PREPARATIONS
    BAMBA, M
    PUISIEUX, F
    MARTY, JP
    CARSTENSEN, JT
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1979, 2 (5-6) : 307 - 315
  • [3] ZERO-ORDER RELEASE HYDROPHILIC MATRIX TABLETS OF BETA-ADRENERGIC BLOCKERS
    BAVEJA, SK
    RAO, KVR
    DEVI, KP
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1987, 39 (1-2) : 39 - 45
  • [4] ON THE EMPLOYMENT OF LAMBDA-CARRAGEENAN IN A MATRIX SYSTEM .2. LAMBDA-CARRAGEENAN AND HYDROXYPROPYLMETHYLCELLULOSE MIXTURES
    BONFERONI, MC
    ROSSI, S
    TAMAYO, M
    PEDRAZ, JL
    DOMINGUEZGIL, A
    CARAMELLA, C
    [J]. JOURNAL OF CONTROLLED RELEASE, 1994, 30 (02) : 175 - 182
  • [5] ON THE EMPLOYMENT OF LAMBDA-CARRAGEENAN IN A MATRIX SYSTEM .1. SENSITIVITY TO DISSOLUTION MEDIUM AND COMPARISON WITH NA CARBOXYMETHYLCELLULOSE AND XANTHAN GUM
    BONFERONI, MC
    ROSSI, S
    TAMAYO, M
    PEDRAZ, JL
    DOMINGUEZGIL, A
    CARAMELLA, C
    [J]. JOURNAL OF CONTROLLED RELEASE, 1993, 26 (02) : 119 - 127
  • [6] On the employment of λ carrageenan in a matrix system.: III.: Optimization of a λ carrageenan-HPMC hydrophilic matrix
    Bonferoni, MC
    Rossi, S
    Ferrari, F
    Bertoni, M
    Bolhuis, GK
    Caramella, C
    [J]. JOURNAL OF CONTROLLED RELEASE, 1998, 51 (2-3) : 231 - 239
  • [7] Modeling of drug release from swellable polymers
    Brazel, CS
    Peppas, NA
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 49 (01) : 47 - 58
  • [8] COHEN JL, 1994, ANAL PROFILES DRUG S, V4, P466
  • [9] ECKHART CG, 1978, ANAL PROFILES DRUG S, V7, P43
  • [10] *FMC CORP, 1993, TECHN LIT